Northwire Canada EditionSaturday, July 11, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Earnings Routine +

TerrAscend Announces Preliminary First Quarter 2026 Financial Results and Schedules Earnings Conference Call

TerrAscend Stabilizes Cash Flow Amidst Cannabis Sector Volatility

By The Northwire Desk — AI Analysis Apr 27, 2026 · 08:35 TSND · 0.91 TERRASCEND CORP. J
Executive Summary
  • TerrAscend Corp. announced preliminary First Quarter 2026 financial results on April 27, 2026.
  • Net Revenue for Q1 2026 was $65.5 million, showing year-over-year growth from continuing operations compared to $64.3 million in Q1 2025.
  • Gross Profit Margin came in at 52.8%, an improvement over Q4 2025 (52.1%) but a decline from Q1 2025 (53.9%).
  • General and Administrative Expenses remained flat quarter-over-quarter.
  • The company generated positive cashflow from operations for the 15th consecutive quarter.
  • Michigan operations are now classified as discontinued operations effective as of the second quarter ended June 30, 2025.
  • Executive Chairman Jason Wild highlighted operational momentum and progress in medical cannabis rescheduling.
Material Impact
  • The news confirms the stability narrative established in Q4 2025 earnings (March 12, 2026), specifically regarding debt refinancing and cash flow generation.
  • Revenue growth is modest (~1.8% YoY) rather than explosive; this aligns with management's "sustainable growth" guidance but lacks the surprise factor required for a Material - Positive rating.
  • Gross margin compression year-over-year (53.9% to 52.8%) presents a hidden risk regarding pricing power or cost inflation, despite the sequential improvement over Q4 2025.
  • The 15th consecutive quarter of positive operating cash flow is a critical defensive metric for a risk-averse investor, validating the balance sheet strength post-refinancing.
  • Classification of Michigan as discontinued operations removes uncertainty regarding asset divestiture proceeds usage (previously noted to reduce debt).
  • Overall impact is incremental confirmation of financial health rather than a fundamental shift in valuation drivers; hence Routine - Positive.
TSND · Price
Company Overview
  • Company: TerrAscend Corp., a multi-state cannabis operator focusing on retail, wholesale, and cultivation.
  • Flagship Project: Apothecarium retail network combined with wholesale distribution channels across five U.S. states and Canada.
  • Operational Scope: Continuing operations include NJ, MD, PA, OH, and Canada; Michigan assets divested as discontinued operations.
  • Strategic Focus: Disciplined M&A strategy focusing on accretive transactions (e.g., Union Chill acquisition) and brand partnerships (Tyson 2.0).
Read the original news release →

More from TERRASCEND CORP. J

Jun 30, 2026 · 08:30

Small accretive NJ acquisition and reverse-split proxy fail to offset lingering debt and Michigan receivership overhang.

M&A / Property Jun 29, 2026 · 11:00

TerrAscend Files Proxy for Reverse Split; Uplisting Remains a Mechanical Step, Not a Fundamental Catalyst

Other Jun 25, 2026 · 16:00

Debt maturity extension and M&A war chest, but conversion discount and Michigan receivership cloud the balance sheet.

Financings Jun 05, 2026 · 14:26

TerrAscend Schedules Special Meeting of Shareholders in Preparation for U.S. Stock Exchange Uplisting

Other May 07, 2026 · 07:10

TerrAscend Confirms Cash Flow Streak Amidst Regulatory Tailwinds

Earnings Mar 31, 2026 · 20:15

Terrascend releases Tyson 2.0 in Pennsylvania, Maryland

Other